News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,198 Results
Type
Article (46067)
Company Profile (333)
Press Release (671798)
Multimedia
Podcasts (61)
Webinars (12)
Section
Business (208184)
Career Advice (2033)
Deals (35884)
Drug Delivery (107)
Drug Development (82816)
Employer Resources (175)
FDA (16539)
Job Trends (15276)
News (352242)
Policy (33623)
Tag
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
Academia (2737)
Academic (1)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (50707)
ALS (91)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (128)
Approvals (16538)
Artificial intelligence (271)
Autoimmune disease (23)
Automation (16)
Bankruptcy (362)
Best Places to Work (12011)
BIOSECURE Act (22)
Biosimilars (109)
Biotechnology (238)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (284)
Cancer (2294)
Cardiovascular disease (181)
Career advice (1698)
Career pathing (31)
CAR-T (155)
Cell therapy (434)
Cervical cancer (19)
Clinical research (67251)
Collaboration (864)
Compensation (538)
Complete response letters (22)
COVID-19 (2670)
CRISPR (46)
C-suite (250)
Cystic fibrosis (103)
Data (2219)
Decentralized trials (2)
Denatured (22)
Depression (46)
Diabetes (285)
Diagnostics (6501)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (127)
Drug pricing (110)
Drug shortages (27)
Duchenne muscular dystrophy (94)
Earnings (87477)
Editorial (38)
Employer branding (21)
Employer resources (149)
Events (115257)
Executive appointments (737)
FDA (17813)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (114)
Generative AI (25)
Gene therapy (325)
GLP-1 (761)
Government (4561)
Grass and pollen (5)
Guidances (59)
Healthcare (19486)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2817)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (313)
IPO (16669)
IRA (41)
Job creations (3718)
Job search strategy (1443)
Kidney cancer (10)
Labor market (38)
Layoffs (483)
Leadership (18)
Legal (8164)
Liver cancer (78)
Lung cancer (324)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (318)
MASH (69)
Medical device (13525)
Medtech (13530)
Mergers & acquisitions (19760)
Metabolic disorders (723)
Multiple sclerosis (81)
NASH (18)
Neurodegenerative disease (97)
Neuropsychiatric disorders (29)
Neuroscience (1958)
NextGen: Class of 2025 (6734)
Non-profit (4638)
Now hiring (39)
Obesity (390)
Opinion (217)
Ovarian cancer (76)
Pain (90)
Pancreatic cancer (85)
Parkinson's disease (151)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (48)
People (58740)
Pharmaceutical (75)
Pharmacy benefit managers (20)
Phase I (20944)
Phase II (29494)
Phase III (22100)
Pipeline (1197)
Policy (147)
Postmarket research (2736)
Preclinical (9000)
Press Release (65)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (255)
Rare diseases (399)
Real estate (6066)
Recruiting (67)
Regulatory (23032)
Reports (46)
Research institute (2453)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (134)
Series B (87)
Service/supplier (12)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (30)
Startups (3708)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (41)
The Weekly (37)
Vaccines (709)
Venture capitalists (42)
Weight loss (261)
Women's health (36)
Worklife (16)
Date
Today (166)
Last 7 days (863)
Last 30 days (2672)
Last 365 days (33625)
2025 (10832)
2024 (36048)
2023 (40879)
2022 (52078)
2021 (56664)
2020 (55091)
2019 (47735)
2018 (36023)
2017 (32932)
2016 (32515)
2015 (38561)
2014 (32248)
2013 (27564)
2012 (29709)
2011 (30270)
2010 (28295)
Location
Africa (768)
Alabama (58)
Alaska (7)
Arizona (236)
Arkansas (13)
Asia (39372)
Australia (6483)
California (6198)
Canada (2024)
China (531)
Colorado (273)
Connecticut (283)
Delaware (147)
Europe (85711)
Florida (920)
Georgia (213)
Idaho (57)
Illinois (555)
India (26)
Indiana (313)
Iowa (11)
Japan (163)
Kansas (107)
Kentucky (23)
Louisiana (11)
Maine (62)
Maryland (904)
Massachusetts (4689)
Michigan (221)
Minnesota (398)
Mississippi (2)
Missouri (84)
Montana (28)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1763)
New Mexico (29)
New York (1764)
North Carolina (1013)
North Dakota (9)
Northern California (2692)
Ohio (204)
Oklahoma (15)
Oregon (37)
Pennsylvania (1384)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (22)
South Dakota (1)
Southern California (2314)
Tennessee (102)
Texas (915)
United States (23507)
Utah (183)
Virginia (152)
Washington D.C. (64)
Washington State (567)
West Virginia (3)
Wisconsin (55)
718,198 Results for "rheos medicines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Press Releases
AKAGERA Medicines, Inc. announces the completion of the first cohort in the IV AKG-100 phase 1 study for the treatment of pulmonary tuberculosis.
April 2, 2025
·
5 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 3, 2025
April 4, 2025
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care
January 6, 2025
·
4 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
2 min read
Press Releases
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 6, 2025
·
4 min read
Press Releases
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
February 25, 2025
·
3 min read
Press Releases
Scipher Medicine and InnoSIGN Announce Partnership to Advance Precision Medicine in Immunology
April 30, 2025
·
3 min read
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
Oragenics, Inc. today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at 12:00 PM ET.
May 17, 2024
·
3 min read
1 of 71,820
Next
